Revenue for Baxter International (BAX)
According to Baxter International's latest reported financial statements, the company's current revenue (TTM) is $11.24B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$11.24B
YoY change
+5.7%
5Y CAGR
-0.7%
Peak year (2012)
$13.94B
Cumulative revenue
$376.97B
Revenue history chart for Baxter International (BAX) from 1985 to 2025
Revenue history table for Baxter International (BAX) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $11.24B | +5.7% | ||
| 2024 | $10.64B | +2.7% | ||
| 2023 | $10.36B | +3.0% | ||
| 2022 | $10.06B | -17.2% | ||
| 2021 | $12.15B | +4.1% | ||
| 2020 | $11.67B | +2.7% | ||
| 2019 | $11.36B | +2.4% | ||
| 2018 | $11.10B | +4.9% | ||
| 2017 | $10.58B | +4.1% | ||
| 2016 | $10.16B | +2.0% | ||
| 2015 | $9.97B | -7.0% | ||
| 2014 | $10.72B | +13.9% | ||
| 2013 | $9.41B | -32.5% | ||
| 2012 | $13.94B | +0.3% | ||
| 2011 | $13.89B | +8.2% | ||
| 2010 | $12.84B | +2.2% | ||
| 2009 | $12.56B | +1.7% | ||
| 2008 | $12.35B | +9.6% | ||
| 2007 | $11.26B | +8.5% | ||
| 2006 | $10.38B | +5.4% | ||
| 2005 | $9.85B | +3.6% | ||
| 2004 | $9.51B | +6.8% | ||
| 2003 | $8.90B | +9.9% | ||
| 2002 | $8.10B | +10.1% | ||
| 2001 | $7.36B | +9.8% | ||
| 2000 | $6.70B | +5.0% | ||
| 1999 | $6.38B | +11.8% | ||
| 1998 | $5.71B | +8.5% | ||
| 1997 | $5.26B | -3.3% | ||
| 1996 | $5.44B | +7.7% | ||
| 1995 | $5.05B | -45.9% | ||
| 1994 | $9.32B | +5.0% | ||
| 1993 | $8.88B | +4.8% | ||
| 1992 | $8.47B | -5.0% | ||
| 1991 | $8.92B | +10.1% | ||
| 1990 | $8.10B | +9.5% | ||
| 1989 | $7.40B | +7.8% | ||
| 1988 | $6.86B | +10.3% | ||
| 1987 | $6.22B | +12.3% | ||
| 1986 | $5.54B | +135.4% | ||
| 1985 | $2.35B | — |
Revenue values are taken from Baxter International's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Baxter International (BAX) revenue is $11.24B – grew 5.7% year-over-year.
Across 2020–2025 (5 years), Baxter International revenue produced a CAGR of -0.7% – sustaining 3 straight years of year-over-year growth.
Between 2012 and 2025, Baxter International revenue declined 19.3%, falling from $13.94B to $11.24B.
The highest annual revenue of $13.94B was reported in 2012. The lowest in the available history was $2.35B in 1985.
Within Healthcare, Baxter International (BAX) ranks 9th among 8 peers we track. The peer median for revenue is $65.09B.
Baxter International Revenue by Year
Baxter International Revenue 2025: $11.24B
Baxter International revenue in 2025 was $11.24B, grew 5.7% from 2024.
Baxter International Revenue 2024: $10.64B
Baxter International revenue in 2024 was $10.64B, edged up 2.7% from 2023.
Baxter International Revenue 2023: $10.36B
Baxter International revenue in 2023 was $10.36B, edged up 3.0% from 2022.
Baxter International Revenue 2022: $10.06B
Baxter International revenue in 2022 was $10.06B, declined 17.2% below 2021.
Baxter International Revenue 2021: $12.15B
Baxter International revenue in 2021 was $12.15B.
See more financial history for Baxter International (BAX).
Sector peers — Revenue
Companies in the same sector as Baxter International, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Baxter International's revenue?
- Latest reported revenue for Baxter International (BAX) is $11.24B (period ending December 31, 2025).
How has Baxter International revenue changed year-over-year?
- Baxter International (BAX) revenue changed +5.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Baxter International revenue?
- Baxter International (BAX) revenue compound annual growth rate is -0.7% over the most recent 5 years available.
When did Baxter International revenue hit its highest annual value?
- Baxter International revenue reached its highest annual value of $13.94B in 2012.
What was Baxter International revenue in 2024?
- Baxter International (BAX) revenue in 2024 was $10.64B.
What was Baxter International revenue in 2025?
- Baxter International (BAX) revenue in 2025 was $11.24B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BAX Overview
Company profile, financial tools, and key metrics
BAX Revenue Counter
Earns $356.54 every second. See per minute, hour, and day.
BAX Earnings Counter
Loses −$30.35 per second. See per minute, hour, and day.
BAX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
BAX What If Invested
What if you had invested $1,000? See historical returns from any date.
BAX How It Makes Money
Discover visual breakdown of $11.24B in revenue — where it comes from and where it goes.
BAX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BAX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BAX Daily Price Character
Steady · 48.3% historical win rate (green days). Streaks & record days.
BAX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BAX Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
BAX Dividend Profile
Yield: 2.13%. Safety: 3/8. See full history.
BAX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BAX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.